Epithelial RANKL Limits Experimental Periodontitis via Langerhans Cells.

Area of Science:

• Immunology
• Periodontology
• Bone Biology

Background:

• Receptor activator of nuclear factor kappa-B ligand (RANKL) is known for driving osteoclast differentiation and is implicated in periodontitis.
• However, RANKL also has diverse immune effects, suggesting a more complex role in periodontitis as a link between bone and immune systems.

Purpose of the Study:

• To investigate the intricate role of RANKL in periodontitis, particularly its potential immunological functions beyond osteoclastogenesis.
• To elucidate the mechanisms by which RANKL influences immune cell populations and inflammation in the gingiva.

Main Methods:

• Ligature-induced periodontitis (LIP) model in mice.
• Analysis of immune cell migration (Langerhans cells, dendritic cells) and T regulatory cell expansion.
• Pharmacological blockade of RANKL signaling using monoclonal antibodies.
• Utilized K14-RANKL transgenic mice with epithelial overexpression of RANKL.

Main Results:

• LIP initially caused bone loss, followed by a halted progression linked to gingival immunosuppression.
• Ligature placement induced migration of RANK-expressing cells and Treg expansion, with subsequent repopulation by monocyte-derived DCs and RANKL upregulation by epithelial cells.
• RANKL blockade reduced Treg cells and prevented immunosuppression; RANKL signaling promoted Langerhans cell differentiation.
• K14-RANKL mice showed altered DC frequencies, increased gingival Treg cells, and significantly reduced alveolar bone loss.

Conclusions:

• RANKL-RANK interactions between gingival epithelial cells and antigen-presenting cells are critical for suppressing gingival inflammation.
• RANKL possesses a previously overlooked protective immunological role in periodontitis, counteracting its known osteoclastogenic activity.